[HTML][HTML] Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplantation for acute myelogenous leukemia

NP Tschernia, V Kumar, DT Moore, BG Vincent… - … and Cellular Therapy, 2021 - Elsevier
ABSTRACT Programmed death 1 (PD-1) is an integral component of acute myelogenous
leukemia (AML) immune evasion, chemotherapy resistance, and disease progression. PD-1 …

Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma

K Hradska, M Kascak, R Hajek… - Expert review of …, 2020 - Taylor & Francis
Introduction: One of the hallmarks of cancerogenesis is the ability of tumor cells to evade the
immune system. They can achieve it by abusing inhibitory immune checkpoint pathways …